Inmedix meets with NICE and NOCRI, establishes subsidiary, Inmedix UK, Ltd.

With its ANS Neuroscan diagnostic™, Inmedix seeks to reduce cost and improve treatment outcomes for patients with rheumatoid arthritis (RA) in the UK based on a broader understanding of the autonomic nervous system (ANS).

Click below to read the full press release.